Sökresultat - Joshua K. Ochieng
- Visas 1 - 1 av 1 resultat
-
1
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers av David H. Peng, B. Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica Konen, Joshua K. Ochieng, Caleb A. Class, Jared J. Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren A. Byers, Don L. Gibbons
Publicerad 2021Artigo
Sökverktyg:
Relaterade ämnen
Biochemistry
Biology
Blockade
Cancer
Cancer research
Cell biology
Colorectal cancer
Combination therapy
Downregulation and upregulation
Gene
Immune checkpoint
Immune system
Immunology
Immunotherapy
Internal medicine
KRAS
Kinase
Lung cancer
MAPK/ERK pathway
MEK inhibitor
Medicine
Melanoma
Oncology
PD-L1
Pharmacology
Receptor
Selumetinib
Targeted therapy